Related Experiment Video
Updated: Feb 23, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
No. 233-Antibiotic Therapy in Preterm Premature Rupture of the Membranes
Mark H Yudin1, Julie van Schalkwyk2, Nancy Van Eyk3
1Toronto, ON.
Insights
This guideline reviews antibiotic use in preterm premature rupture of membranes (PPROM). Evidence supports judicious antibiotic administration to reduce maternal and neonatal complications.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
Background:
- Preterm premature rupture of membranes (PPROM) is a significant obstetric complication.
- Effective management strategies, including antibiotic use, are crucial for improving outcomes.
Purpose of the Study:
- To synthesize evidence on antibiotic use in PPROM.
- To provide evidence-based recommendations for clinical practice.
Main Methods:
- Comprehensive literature search of multiple databases (Medline, EMBASE, CINAHL, Cochrane Library).
- Inclusion of systematic reviews, RCTs, and observational studies.
- Inclusion of grey literature and guideline updates through July 2008.
Main Results:
- Antibiotic treatment impacts maternal infection, chorioamnionitis, and neonatal morbidity/mortality.
- Implementation of guidelines aids practitioners in managing PPROM with antibiotics.
- Appropriate patient management leads to improved outcomes.
Conclusions:
- Evidence supports specific approaches to antibiotic use in PPROM.
- Recommendations aim to optimize care and reduce adverse events.
Objective:
To review the evidence and provide recommendations on the use of antibiotics in preterm premature rupture of the membranes (PPROM).
Outcomes:
Outcomes evaluated include the effect of antibiotic treatment on maternal infection, chorioamnionitis, and neonatal morbidity and mortality.
Evidence:
Published literature was retrieved through searches of Medline, EMBASE, CINAHL, and The Cochrane Library, using appropriate controlled vocabulary and key words (PPROM, infection, and antibiotics). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. There were no date or language restrictions. Searches were updated on a regular basis and new material incorporated in the guideline to July 2008. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.
Values:
The evidence obtained was reviewed and evaluated by the Infectious Diseases Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC) under the leadership of the principal authors, and recommendations were made according to guidelines developed by the Canadian Task Force on Preventive Health Care.
Benefits, Harms, And Costs:
Guideline implementation should assist the practitioner in developing an approach to the use of antibiotics in women with PPROM. Patients will benefit from appropriate management of this condition.
Validation:
This guideline has been reviewed and approved by the Infectious Diseases Committee and the Maternal Fetal Medicine Committee of the SOGC, and approved by the Executive and Council of the SOGC.
Sponsor:
The Society of Obstetricians and Gynaecologists of Canada.
More Related Videos
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
00:57Antibiotic Selection
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy